Home Value Investing Raffles Medical Group Valuation Analysis

Raffles Medical Group Valuation Analysis

When you purchase through our sponsored links, we may earn a commission. By using this website you agree to our T&Cs.

Est. in 1976, Raffles Medical Group (RMG) has grown from only two clinics to be one of the leading medical groups in Singapore with the largest private group practice. The Group operates within three business segments, mainly healthcare services, hospital services and investment holdings.

Investment Thesis:

  • Despite Raffles Medical Group’s fundamentals and strong economic moat, we believe paying a premium of 56%% based on current market prices to be unjustified.
  • Stronger growth in Healthcare segment from FY2016E onwards with potential risks from competition within the region.

The full report can be found below and free to be downloaded via Scribd.

Raffles Medical Group

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

SG Value Investor
Editor

Want Financial Guidance Sent Straight to You?

  • Pop your email in the box, and you'll receive bi-weekly emails from ValueWalk.
  • We never send spam — only the latest financial news and guides to help you take charge of your financial future.